262 related articles for article (PubMed ID: 30927362)
21. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
22. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
[TBL] [Abstract][Full Text] [Related]
23. Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine.
Schwab K; Chasapopoulou Z; Frahm S; Magbagbeolu M; Cranston A; Harrington CR; Wischik CM; Theuring F; Riedel G
Cell Signal; 2022 Sep; 97():110386. PubMed ID: 35709886
[TBL] [Abstract][Full Text] [Related]
24. Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion.
Aceves Buendia JJ; Tiroshi L; Chiu WH; Goldberg JA
Eur J Neurosci; 2019 Mar; 49(6):824-833. PubMed ID: 28922504
[TBL] [Abstract][Full Text] [Related]
25. Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD.
Picconi B; Ghiglieri V; Bagetta V; Barone I; Sgobio C; Calabresi P
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S145-9. PubMed ID: 18583173
[TBL] [Abstract][Full Text] [Related]
26. Alpha-synuclein is involved in manganese-induced spatial memory and synaptic plasticity impairments via TrkB/Akt/Fyn-mediated phosphorylation of NMDA receptors.
Ma Z; Liu K; Li XR; Wang C; Liu C; Yan DY; Deng Y; Liu W; Xu B
Cell Death Dis; 2020 Oct; 11(10):834. PubMed ID: 33033239
[TBL] [Abstract][Full Text] [Related]
27. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
[TBL] [Abstract][Full Text] [Related]
28. Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.
Akopian G; Crawford C; Beal MF; Cappelletti M; Jakowec MW; Petzinger GM; Zheng L; Gheorghe SL; Reichel CM; Chow R; Walsh JP
J Neurosci; 2008 Sep; 28(38):9585-97. PubMed ID: 18799690
[TBL] [Abstract][Full Text] [Related]
29. Pathway-Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease.
Tanimura A; Shen W; Wokosin D; Surmeier DJ
Mov Disord; 2022 Jun; 37(6):1164-1174. PubMed ID: 35485341
[TBL] [Abstract][Full Text] [Related]
30. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
Febbraro F; Sahin G; Farran A; Soares S; Jensen PH; Kirik D; Romero-Ramos M
Neurobiol Dis; 2013 Aug; 56():47-58. PubMed ID: 23567651
[TBL] [Abstract][Full Text] [Related]
31. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J
Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815
[TBL] [Abstract][Full Text] [Related]
32. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
33. Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors.
Saulle E; Centonze D; Martín AB; Moratalla R; Bernardi G; Calabresi P
Stroke; 2002 Dec; 33(12):2978-84. PubMed ID: 12468800
[TBL] [Abstract][Full Text] [Related]
34. GluN2B-containing NMDA receptors contribute to the beneficial effects of hydrogen sulfide on cognitive and synaptic plasticity deficits in APP/PS1 transgenic mice.
Yang YJ; Zhao Y; Yu B; Xu GG; Wang W; Zhan JQ; Tang ZY; Wang T; Wei B
Neuroscience; 2016 Oct; 335():170-83. PubMed ID: 27581687
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of convergent synaptic inputs onto pyramidal neurons in somatosensory cortex: dependence on brain wave frequencies and NMDA receptor subunit composition.
Pilli J; Kumar SS
Neuroscience; 2014 Jul; 272():271-85. PubMed ID: 24814019
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms underlying striatal synaptic plasticity: relevance to chronic alcohol consumption and seeking.
Blackwell KT; Salinas AG; Tewatia P; English B; Hellgren Kotaleski J; Lovinger DM
Eur J Neurosci; 2019 Mar; 49(6):768-783. PubMed ID: 29602186
[TBL] [Abstract][Full Text] [Related]
37. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of α-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity.
Yang J; Hertz E; Zhang X; Leinartaité L; Lundius EG; Li J; Svenningsson P
Neurosci Lett; 2016 Jan; 611():51-8. PubMed ID: 26610904
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity.
Centonze D; Grande C; Saulle E; Martin AB; Gubellini P; Pavón N; Pisani A; Bernardi G; Moratalla R; Calabresi P
J Neurosci; 2003 Sep; 23(24):8506-12. PubMed ID: 13679419
[TBL] [Abstract][Full Text] [Related]
40. NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology.
Mellone M; Zianni E; Stanic J; Campanelli F; Marino G; Ghiglieri V; Longhi A; Thiolat ML; Li Q; Calabresi P; Bezard E; Picconi B; Di Luca M; Gardoni F
Neurobiol Dis; 2019 Jan; 121():338-349. PubMed ID: 30261285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
